Moderna, mRNA and bird flu

The president announced a major AI investment project, which Oracle Chairman Larry Ellison said could be used to cure cancer.
Moderna is developing an mRNA-based vaccine for norovirus, now in Phase 3 trials, with hopes of approval by 2026 to combat the highly contagious stomach virus.
Vaxxas and CEPI advance US$ 4.8 million programme for needle-free thermostable mRNA vaccines: Cambridge, Massachusetts Friday, January 24, 2025, 14:00 Hrs [IST] Vaxxas, a clinical ...
Chairman Larry Ellison highlighted the AI's potential in the development of mRNA-based cancer vaccines. Read more here.
Moderna conducts phase 3 trial for norovirus vaccine as cases rise in the U.S., with results expected in late 2025 or early 2026.
Following the lead of previous work on mRNA-based vaccines, therapies for spinal cord injuries and more, the method relies upon mineral-coated microparticles to deliver mRNA that encodes for ...
Traditional vaccines typically focus on the most accessible parts of viruses, which are often the rapidly mutating ...
Larry Ellison unveiled plans for an AI-driven cancer vaccine system that could deliver personalized treatments within 48 ...